About: Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 1998

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 1998 (uk) article scientifique publié en 1998 (fr) im März 1998 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 1998 (ast) scientific article published on 01 March 1998 (en)
publication date	wds:Q74238242-9243072B-AFB9-4488-8948-5F1DE0AE3B08
publication date	1998-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74238242-D3E3C698-AE7E-4B7D-BAE1-7DAEF2CDC4BB
language of work or name	English
author name string	wds:Q74238242-3A6BD480-E795-47CD-86C3-E62C7126FD4D wds:Q74238242-5F6ACC42-CFA9-4339-87DE-4ABFF0E1769D wds:Q74238242-92DF2133-B00E-46E8-AE1E-AE2991E545A2 wds:Q74238242-97B7D8A8-E509-40BE-ABA0-564218636747 wds:Q74238242-D12820A9-6CF6-4285-AD0D-2C790A7574B1 wds:Q74238242-D702B0E4-93EA-4DBF-B4BD-B91DE405C30F wds:Q74238242-EED5E71A-7A61-41F4-8655-5403C0024F00 wds:Q74238242-F7F96DCE-150F-4B46-B27E-2CA56A79EAE9
author name string	D Davidson J Kattwinkel C T Chang E S Barefield R Straube G Dudell J Rhines M Damask
rdfs:label	Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group (en) Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group (nl)
skos:prefLabel	Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group (en) Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group (nl)
name	Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group (en) Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group (nl)
title	wds:Q74238242-355CC2B5-0052-4665-B760-1B6AA9097FAC
title	Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group (en)
page(s)	wds:Q74238242-2838F27D-6446-4332-9CD5-207A763D800F
page(s)	325-334
instance of	wds:Q74238242-F12D8DE4-6587-4E80-AFDD-0F1BD0EE5782
instance of	scholarly article
main subject	wds:Q74238242-3A8FA068-E8C2-4085-B69B-6C4001B538D4 wds:Q74238242-74CCEF6B-AB50-41B7-A8A7-5A7E06BD0C52
main subject	placebo pulmonary hypertension
PubMed ID	wds:Q74238242-C3D4EED0-F720-420A-A9A9-6DDD5D00D5B8
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9480993
PubMed ID	9480993
published in	wds:Q74238242-E75B6346-9876-4EB6-B7CD-84D0C7D8ED8A
published in	Pediatrics
issue	wds:Q74238242-A49ED6B6-04B1-4D18-96AD-2AB3E4345E29
volume	wds:Q74238242-F007109F-F925-4325-BA4E-F30DEFBDFBA1
issue	3 Pt 1
volume	101
DOI	wds:Q74238242-1624B2C6-84EE-4BDE-AC7B-3502BDF6E3D7
DOI	http://dx.doi.org/10.1542/PEDS.101.3.325
DOI	10.1542/PEDS.101.3.325
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74238242
is cites work of	Utility of large-animal models of BPD: chronically ventilated preterm lambs Antidepressant use in pregnancy: a critical review focused on risks and controversies Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: A review Blue babies and nitrate-contaminated well water The epidemiology of respiratory failure in neonates born at an estimated gestational age of 34 weeks or more. Histologic chorioamnionitis: an occult marker of severe pulmonary hypertension in the term newborn Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management Nitric oxide for respiratory failure in infants born at or near term Inhaled NO as a therapeutic agent Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial Can nitric oxide-based therapy prevent bronchopulmonary dysplasia? Inhaled nitric oxide in the management of preterm infants with severe respiratory failure Pathophysiology, management, and outcome of persistent pulmonary hypertension of the newborn: a clinical review Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. Inhaled nitric oxide therapy during the transport of neonates with persistent pulmonary hypertension or severe hypoxic respiratory failure Drug treatment of pulmonary hypertension in children Inhaled nitric oxide alleviates hyperoxia suppressed phosphatidylcholine synthesis in endotoxin-induced injury in mature rat lungs Nitric oxide in the lung: therapeutic and cellular mechanisms of action Epigenetic regulation of pulmonary arterial hypertension Response to inhaled nitric oxide in premature and term neonates Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia Nasal nitric oxide in man Nitric oxide for the adjunctive treatment of severe malaria: hypothesis and rationale Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling Extracorporeal membrane oxygenation for severe acute respiratory failure Severe persistent pulmonary hypertension of the newborn in a setting where limited resources exclude the use of inhaled nitric oxide: successful treatment with sildenafil Nitric oxide and pulmonary hypertension Update on PPHN: mechanisms and treatment. Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension Role of iNO in the modulation of pulmonary vascular resistance Initial dosing of inhaled nitric oxide in infants with hypoxic respiratory failure. Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial Dose response to nitric oxide in adult cardiac surgery patients Cardiac abnormalities in birth asphyxia Role of Inhaled Nitric Oxide in the Management of Severe Acute Respiratory Distress Syndrome Congenital Diaphragmatic hernia - a review Inhaled nitric oxide and gentle ventilation in the treatment of pulmonary hypertension of the newborn--a single-center, 5-year experience. Withdrawal of Inhaled Nitric Oxide from Nonresponders after Short Exposure Extracorporeal membrane oxygenation 2001. The odyssey continues Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Therapeutic approaches using nitric oxide in infants and children.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software